DLTR
38
4
DVN
18
2
IPG
53
4
CMS
60
2
CINF
51
4
PH
73
3
SO
57
2
NTAP
66
2
M
25
5
STT
64
4
BXP
52
2
SRE
66
3
MAR
65
2
C
60
2
AMGN
38
-6
MAS
56
5
UNP
45
6
STZ
57
2
PBI
65
5
DOW
34
4
DLTR
38
4
DVN
18
2
IPG
53
4
CMS
60
2
CINF
51
4
PH
73
3
SO
57
2
NTAP
66
2
M
25
5
STT
64
4
BXP
52
2
SRE
66
3
MAR
65
2
C
60
2
AMGN
38
-6
MAS
56
5
UNP
45
6
STZ
57
2
PBI
65
5
DOW
34
4
Financhill
Back

Regenxbio Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
18

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
450.53
Seasonality Move:
11.1%
Sell
18
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.18. The Score for RGNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $450.37. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $450.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.02 Sell
Chaikin Money Flow: -473643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.97 - 10.71) Sell
Bollinger Bands (100): (9.86 - 12.8) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.97 Sell
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: 44374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.09 - 494.97) Sell
Bollinger Bands (100): (465.11 - 492.19) Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Sell
20-day SMA: 9.77 Sell
50-day SMA: 10.34 Sell
200-day SMA: 14.27 Sell
8-day EMA: 9.84 Sell
20-day EMA: 9.96 Sell
50-day EMA: 10.39 Sell
200-day EMA: 13.22 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 468.86 Sell
20-day SMA: 479.26 Sell
50-day SMA: 474.44 Sell
200-day SMA: 453.81 Sell
8-day EMA: 465.05 Sell
20-day EMA: 474.27 Sell
50-day EMA: 475.71 Sell
200-day EMA: 452.67 Sell

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.54 per share, and an increase next year of $18.39 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):